Neurological Research

Multiple sclerosis: current knowledge and future directions
pp. 227-229(3)
Author: Minagar, Alireza

Multiple sclerosis as a vascular disease
pp. 230-235(6)
Authors: Minagar, Alireza; Jy, Wenche; Jimenez, J.J.; Alexander, J. Steven

The B cell response in multiple sclerosis
pp. 236-244(9)
Authors: Owens, Gregory P.; Bennett, Jeffrey L.; Gilden, Donald H.; Burgoon, Mark P.

The role of CD4+ T-cells in the development of MS
pp. 245-249(5)
Authors: Delgado, Sylvia; Sheremata, William A.

A potential role for CD8+ T-cells as regulators of CNS vascular permeability
pp. 250-255(6)
Authors: Suidan, Georgette L.; Pirko, Istvan; Johnson, Aaron J.

The role of CD8+ T-cells in lesion formation and axonal dysfunction in multiple sclerosis
pp. 256-261(6)
Authors: McDole, Jeremiah; Johnson, Aaron J.; Pirko, Istvan

Positivity of cytomegalovirus antibodies predicts a better clinical and radiological outcome in multiple sclerosis patients
pp. 262-269(8)
Authors: Zivadinov, Robert; Nasuelli, Davide; Tommasi, Maria Antonietta; Serafin, Maurizia; Bratina, Alessio; Ukmar, Maja; Pirko, Istvan; Johnson, Aaron J.; Furlan, Christina; Pozzi-Mucelli, Roberto S.; Monti-Bragadin, Luisa; Grop, Attilio; Zambon, Massimo; Antonello, Rodolfo M.; Cazzato, Giuseppe; Zorzon, Marino

Impact of IVIg on the interaction between activated T cells and microglia
pp. 270-274(5)
Authors: Janke, Angela D.; Yong, V. Wee

Effect of MRI coregistration on serial short-term brain volume changes in multiple sclerosis
pp. 275-279(5)
Authors: Fritz, David A.; Dwyer, Michael G.; Bagnato, Francesca; Watts, Kelly L.; Bratina, Alessio; Zorzon, Marino; Durastanti, Valentina; Locatelli, Laura; Millefiorini, Enrico; Zivadinov, Robert

Role of magnetic resonance spectroscopy in diagnosis and management of multiple sclerosis
pp. 280-283(4)
Authors: Gonzalez-Toledo, Eduardo; Kelley, Roger E.; Minagar, Alireza

Neuropsychiatric manifestations of multiple sclerosis
pp. 284-290(7)
Authors: Pinkston, James B.; Alekseeva, Nadejda

Natalizumab and progressive multifocal leukoencephalopathy: migrating towards safe adhesion molecule therapy in multiple sclerosis
pp. 291-298(8)
Author: Bennett, Jeffrey L.

Progressive multifocal leukoencephalopathy: lessons from AIDS and natalizumab
pp. 299-305(7)
Authors: Berger, Joseph R.; Houff, Sidney

Treatment of symptoms in multiple sclerosis
pp. 306-315(10)
Author: Schwendimann, Robert N.

Uric acid in multiple sclerosis
pp. 316-319(4)
Authors: Koch, Marcus; De Keyser, Jacques

Neurosurgical treatment of multiple sclerosis
pp. 320-325(6)
Authors: Patwardhan, Ravish V.; Minagar, Alireza; Kelley, Roger E.; Nanda, Anil

Patterns and significance of concomitant central and peripheral inflammatory demyelination
pp. 326-333(8)
Authors: Rezania, Kourosh; Arnason, Barry G.; Soliven, Betty

Ischemic demyelination
pp. 334-340(7)
Author: Kelley, Roger E.

The clinical course of acute disseminated encephalomyelitis
pp. 341-347(7)
Author: Wingerchuk, Dean M.

Evidence for humoral autoimmunity in neuromyelitis optica
pp. 348-353(6)
Author: Wingerchuk, Dean M.

Progressive necrotizing myelopathy: part of the spectrum of neuromyelitis optica?
pp. 354-359(6)
Authors: Okai, Annette F.; Muppidi, Srikanth; Bagla, Ritu; Leist, Thomas P.

Central pontine myelinolysis, an update
pp. 360-366(7)
Authors: Kumar, Suresh; Fowler, Marjorie; Gonzalez-Toledo, Eduardo; Jaffe, S.L.